Evidence map›Paper›PMID 40551011›Full record

ArticleThe EMBO journal2025

WIP1 mutations suppress DNA damage triggered bypass of the mitotic timer.

Tomoaki Sobajima, Luke J Fulcher, Caleb Batley, Susanna J Alsop, Jonah Veakins, Francis A Barr

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Veterinary sciences · 2026
    Article
  2. When the Clock Is Ticking: The Role of Mitotic Duration in Cell Fate Determination.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tomoaki SobajimaDepartment of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK.ORCID http://orcid.org/0000-0002-0753-5361
Luke J FulcherDepartment of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK.
Caleb BatleyDepartment of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK.ORCID http://orcid.org/0000-0002-8725-6089
Susanna J AlsopDepartment of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK.ORCID http://orcid.org/0009-0000-4815-4656
Jonah VeakinsDepartment of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK.
Francis A BarrDepartment of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK. francis.barr@bioch.ox.ac.uk.ORCID http://orcid.org/0000-0001-7518-253X

Funding

Cancer Research UK (CRUK) DRCRPG-May23/100006
6 · The paper itself

Abstract

Prolonged mitosis results in the destruction of MDM2, initiating a p53-dependent G1 cell-cycle arrest in the absence of DNA damage. Here, we investigate how DNA damage earlier in the cell cycle affects this mitotic-timer response. We find that G2-DNA damage triggers highly penetrant bypass of mitosis and of the mitotic timer, generating tetraploid cells arrested in G1. Collapse of G2 to G1 after DNA damage is initiated by p21-mediated CDK2 inhibition and rendered irreversible by the destruction of G2/M-cyclins A and B. This behaviour is altered in cells with cancer-associated mutations in the p53-phosphatase WIP1 (PPM1D), which increase the threshold for DNA-damage signalling, enabling DNA-damaged G2 cells to enter mitosis with elevated levels of MDM2, thereby suppressing mitotic-timer-dependent G1 cell-cycle arrest. Importantly, neither WIP1 mutations nor knockout prevent p53-dependent G1-arrest in response to prolonged mitosis in the absence of DNA damage. Prolonged mitosis and G2-DNA damage thus promote p53-dependent G1 cell-cycle exit through discrete routes with differential requirements for WIP1 and genotoxic stress.

Indexed as

DNA DamageMitosisMutationProtein Phosphatase 2CHumansProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53MDM2 protein, humanPPM1D protein, humanProtein Phosphatase 2CProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53Cell CycleCell Cycle CheckpointsDNA DamageMitosis

Identifiers

PMID40551011
PMCPMC12316910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.